ABPI Code of Practice – FPM consultation event

Tuesday 21 July 2020
16:00 - 17:00

What is it and how will it work?

The ABPI has launched a consultation on the proposed 2021 Code of Practice for the pharmaceutical industry. They aim to future proof the Code, make it more accessible, and incorporate mandatory changes from the 2019 EFPIA Code of Practice.

Link to the consultation (ABPI) consultation

Given the importance of the Code to the work of the FPM membership, we obviously want to develop a comprehensive and well-informed response to the consultation.

As a first step, anyone who would like to be involved is invited to attend a virtual kick-off meeting, hosted by Dr Sharon McCullough. The aims of the meeting are to hear the views of members, identify the key topics for FPM to comment on, and to map out the process for developing our response.

The meeting will be held on the 21 July, 16:00-17:00. Further details on the format of the event will follow.

Please contact Ben Cottam (b.cottam@fpm.org.uk) if you have any comments or queries at this stage.

Registration is now closed for this event. Please email b.cottam@fpm.org.uk if you have any queries.

About The ABPI Code of Practice for the Pharmaceutical Industry

The Code sets standards for the promotion of medicines to health professionals and other relevant decision makers in the UK. It includes requirements for the provision of information to patients and the public and relationships with patient groups. The Code also applies to a number of areas that are non-promotional.

The Code covers:

  • journal, direct mail and digital advertising
  • the activities of representatives, including any materials used by them
  • the supply of samples
  • the provisions of inducements to prescribe, supply, administer, buy or sell medicines, by the gift, offer or promise of any benefit or bonus whether in money or in kind
  • the provision of hospitality
  • promotional meetings
  • the sponsorship of scientific and other meetings including payment of travel and accommodation expenses
  • all other sales promotion including exhibitions and digital communications
  • the provision of information to the public
  • relationships with patient organisations.

The detailed provisions in the Code aim to ensure that pharmaceutical companies operate in a responsible, ethical and professional manner.

This information is taken from http://www.pmcpa.org.uk/thecode/Pages/default.aspx